2024 | Effectiveness of COVID-19 vaccines against severe outcomes in cancer patients: Real-world evidence from self-controlled risk interval and retrospective cohort studies | 최남경; 김충종; 박민아 | Article |
2008 | Exact Tests for Epidemiological Risks under Independent Negative Binomial Sampling for Rare Events in Clinical Trials | 강승호 | Article |
2023 | Immunogenicity of SARS-CoV-2 Vaccine in Kidney Transplant Recipients: A Cross-Sectional Study in Korea | 정혜선; 송승환; 김수경 | Article |
2016 | In hot pursuit of the first vaccine against respiratory syncytial virus | 장준; 김주영 | Review |
2022 | Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine | 김충종 | Article |
2018 | Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine | 김경효 | Article |
2017 | Microbial compositional changes in broiler chicken cecal contents from birds challenged with different Salmonella vaccine candidate strains | 김선애 | Article |
2024 | One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjects | 김충종 | Article |
2015 | Phase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine | 김경효 | Article |
2015 | Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC((R))) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial | 김경효 | Article |
2019 | Single mucosal vaccination targeting nucleoprotein provides broad protection against two lineages of influenza B virus | 장준 | Article |
2018 | Vaccination with a latch peptide provides serotypeindependent protection against group B streptococcus infection in mice | 임재향 | Article |
2019 | Vaccine containing G protein fragment and recombinant baculovirus expressing M2 protein induces protective immunity to respiratory syncytial virus | 장준 | Article |